{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T22:51:25Z","timestamp":1695768685250},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1990,6,1]],"date-time":"1990-06-01T00:00:00Z","timestamp":644198400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[1990,6]]},"DOI":"10.1007\/bf00973747","type":"journal-article","created":{"date-parts":[[2005,1,13]],"date-time":"2005-01-13T09:45:36Z","timestamp":1105609536000},"page":"587-591","source":"Crossref","is-referenced-by-count":11,"title":["Studies on new, centrally active and reversible acetylcholinesterase inhibitors"],"prefix":"10.1007","volume":"15","author":[{"given":"Frank","family":"Arnal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucien J.","family":"Cot\ufffd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Ginsburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glen D.","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Naini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Sano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0006-8993(79)90336-6","volume":"171","author":"P. Davis","year":"1979","unstructured":"Davis, P. 1979. Neurotransmitter-related enzymes in senile dementia of the Alzheimer's type. Brain Res 171:319?327.","journal-title":"Brain Res"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1126\/science.6338589","volume":"219","author":"J. T. Coyle","year":"1983","unstructured":"Coyle, J. T., Price, D. L., DeLong, M. R. 1983. Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 219:1184?1190.","journal-title":"Science"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1212\/WNL.31.12.1552","volume":"31","author":"P. Etienne","year":"1981","unstructured":"Etienne, P., Dastor, D., Gauthier, S., et al. 1981. Alzheimer's disease: lack of effect of lechitic treatment of three months. Neurology 31:1552?1554.","journal-title":"Neurology"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1176\/ajp.139.6.838","volume":"139","author":"K. L. Davis","year":"1982","unstructured":"Davis, K. L., Mohs, R. C. 1982. Enhancement of memory processes in Alzheimer's disease with multiple-dose intravenous physostigmine. Am. J. Psychiatry 139:1421?1424.","journal-title":"Am. J. Psychiatry"},{"key":"CR5","first-page":"451","volume":"19","author":"K. L. Davis","year":"1983","unstructured":"Davis, K. L., Mohs, R. C., Davis, B. M. et al. 1983. Oral physostigmine in Alzheimer's disease. Psychopharmacol Bull 19:451?453.","journal-title":"Psychopharmacol Bull"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/0278-5846(86)90032-1","volume":"10","author":"L. J. Thal","year":"1986","unstructured":"Thal, L. J., Masur, D. M., Sharpless, N. S., et al. 1986. Acute and chronic effects of oral physostigmine and lecithin in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 10:627?636.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"CR7","unstructured":"Sano, M., Stern, Y., Stricks, L., and Mayeux, R. Physostigmine response in probable Alzheimer's disease is related to duration of exposure. Neurology (in press)."},{"key":"CR8","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1056\/NEJM198611133152001","volume":"315","author":"W. K. Summers","year":"1986","unstructured":"Summers, W. K., Majovski, L. V., March, G. M., et al. 1986. Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer's type. N Engl J Med 315:1241?1245.","journal-title":"N Engl J Med"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1432-1033.1986.tb09646.x","volume":"157","author":"M. Brufani","year":"1986","unstructured":"Brufani, M., Marta, M., Pomponi, M. 1986. Anticholinesterase activity of a new carbamate, heptylphysostigmine, in view of its use in patients with Alzheimer-type dementia. Eur J Biochem 157:115?120.","journal-title":"Eur J Biochem"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0014-5793(86)80606-8","volume":"201","author":"A. Brossi","year":"1986","unstructured":"Brossi, A., Schonenberger, B., Clark, O. E., and Ray, R. 1986. Inhibition of acetylcholinesterase from electric eel by (?)- and (+)- physostigmine and related compounds. FEBS Lett 201:190?192.","journal-title":"FEBS Lett"},{"key":"CR11","first-page":"20","volume":"136","author":"R. L. Irwin","year":"1962","unstructured":"Irwin, R. L., Hein, M. M. 1962. The inhibition of rat brain cholinesterase after administration of the dimethylcarbamates of deoxy- demethyllycoramine, neostigmine or physostigmine. J Pharmacol Exp Ther 136:20?25.","journal-title":"J Pharmacol Exp Ther"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/0006-2952(82)90009-0","volume":"31","author":"A. Galli","year":"1982","unstructured":"Galli, A., Renzi, G., Grazzini, E., et al. 1982. Reversible inhibition of acetylcholinesterase by eseroline, an opioid agonist structurally related to physostigmine (eserine) and morphine. Biochem Pharmacol 31:1233?1239.","journal-title":"Biochem Pharmacol"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1016\/0006-2952(67)90019-6","volume":"16","author":"R. Kitz","year":"1967","unstructured":"Kitz, R., Ginsburg, S., and Wilson, I. B. 1967. The reaction of acetylcholinesterase with O-dimethylcarbamyl esters of quaternary quinolinium compounds. Biochem. Pharmacol 16:2201?2209.","journal-title":"Biochem. Pharmacol"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0003-2697(75)90423-6","volume":"64","author":"C. D. Johnson","year":"1975","unstructured":"Johnson, C. D., and Russell, R. L. 1975. A rapid, simple radiometric assay for cholinesterase, suitable for multiple determinations. Anal Biochem 64:229?238.","journal-title":"Anal Biochem"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1748-1716.1958.tb01537.x","volume":"42","author":"E. Giacibini","year":"1958","unstructured":"Giacibini, E., and Holmstedt, B. 1958. Cholinesterase content of certain regions of the spinal cord as judged by histochemical and cartesian diver technique. Acta Physiol Scand 42:12?27.","journal-title":"Acta Physiol Scand"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1016\/S0021-9258(18)64619-8","volume":"235","author":"I. B. Wilson","year":"1960","unstructured":"Wilson, I. B., Hatch, M. A., and Ginsburg, S. 1960. Carbamylation of acetylcholinesterase. J. Biol Chem. 235:2312?2315.","journal-title":"J. Biol Chem."},{"key":"CR17","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0378-4347(00)84449-7","volume":"274","author":"J. Y. Hsieh","year":"1983","unstructured":"Hsieh, J. Y., Yang, R. K., and Davis, K. L. 1983. High-performance liquid chromatographic determination of tetrahydroaminoacridine in human and rat tissues using a rapid Sep-pak C18 extraction. J Chromatogr 274:388?392.","journal-title":"J Chromatogr"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/j.2042-7158.1979.tb13660.x","volume":"31","author":"A. Galli","year":"1979","unstructured":"Galli, A., Renjii, G., Bartolini, A., et al. 1979. Inhibition of [3H] naloxone binding in homogenates of rat brain by eseroline, a drug with analgesic activity, related to physostigmine. J. Pharm Pharmacol 31:784?786.","journal-title":"J. Pharm Pharmacol"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00973747.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00973747\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00973747","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T23:51:05Z","timestamp":1625356265000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00973747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,6]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1990,6]]}},"alternative-id":["BF00973747"],"URL":"https:\/\/doi.org\/10.1007\/bf00973747","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,6]]}}}